Barclays
NHTC icon

Barclays’s Natural Health Trends NHTC Stock Holding History

Barclays’s Portfolio NHTC Stock Details NHTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$864 Buy
+488
New +$1.28K ﹤0.01% 4941
2025
Q2 		– Sell
-18
Closed -$91 – 5444
2025
Q1 		$91 Hold
18
– – ﹤0.01% 5131
2024
Q4 		$83 Hold
18
– – ﹤0.01% 5186
2024
Q3 		$107 Buy
+18
New +$123 ﹤0.01% 5180
2020
Q1 		– Sell
-54
Closed – – 6357
2019
Q4 		$0 Sell
54
-55
-50% -$352 ﹤0.01% 6652
2019
Q3 		$1K Sell
109
-22,103
-100% -$162K ﹤0.01% 6598
2019
Q2 		$178K Buy
22,212
+18,710
+534% +$196K ﹤0.01% 5219
2019
Q1 		$46K Buy
3,502
+2,049
+141% +$30.6K ﹤0.01% 5938
2018
Q4 		$27K Sell
1,453
-2,696
-65% -$59.3K ﹤0.01% 5771
2018
Q3 		$96K Buy
4,149
+3,550
+593% +$87K ﹤0.01% 5579
2018
Q2 		$15K Sell
599
-948
-61% -$19.8K ﹤0.01% 6339
2018
Q1 		$29K Sell
1,547
-40
-3% -$678 ﹤0.01% 6267
2017
Q4 		$24K Buy
1,587
+1,071
+208% +$20.2K ﹤0.01% 6209
2017
Q3 		$13K Sell
516
-125
-20% -$2.85K ﹤0.01% 5999
2017
Q2 		$18K Sell
641
-726
-53% -$20.7K ﹤0.01% 5842
2017
Q1 		$40K Sell
1,367
-237
-15% -$6.37K ﹤0.01% 5460
2016
Q4 		$40K Sell
1,604
-1,244
-44% -$31.3K ﹤0.01% 5300
2016
Q3 		$80K Buy
2,848
+2,844
+71,100% +$88.1K ﹤0.01% 4659
2016
Q2 		$0 Sell
4
-8
-67% -$261 ﹤0.01% 6521
2016
Q1 		$0 Buy
+12
New +$326 ﹤0.01% 6345
2015
Q4 		– Sell
-41
Closed -$1.8K – 6377
2015
Q3 		$1K Sell
41
-110
-73% -$3.33K ﹤0.01% 6569
2015
Q2 		$6K Buy
+151
New +$4.47K ﹤0.01% 6358

Other funds holding NHTC

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Barclays's NHTC Position: Q2 2026 in Review

Barclays opened a new position in Natural Health Trends (NHTC) in Q2 2026: 488 shares worth $864. The stake represents ﹤0.01% of the portfolio and ranks #4941 among its holdings. This is a return to the name: Barclays previously reported a position in NHTC as recently as Q1 2025.

Barclays first reported a position in NHTC in Q2 2015 and has held it in 22 quarters since. The position peaked at $178K in Q2 2019. 22 funds tracked by Wall St. Rank hold NHTC as of Q2 2026.

  • Barclays held 488 shares of Natural Health Trends worth $864 as of Q2 2026.
  • Natural Health Trends was a new Barclays position in Q2 2026.
  • Natural Health Trends made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4941 holding.
  • Barclays first reported a position in Natural Health Trends in Q2 2015 and has held it in 22 quarters since.
  • Barclays's Natural Health Trends position peaked at $178K in Q2 2019.
  • 22 funds tracked by Wall St. Rank held Natural Health Trends as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.